Persist AI is revolutionizing pharmaceutical formulation development by integrating artificial intelligence and robotics to expedite the creation of drug formulations. Traditionally, developing long-acting injectables and other complex drug formulations can take several years; Persist AI's innovative approach reduces this timeline significantly, enabling faster delivery of life-saving medications to patients.
Key Features and Functionality:
- Cloud Lab: A remote-access platform that allows pharmaceutical scientists to design and execute formulation experiments via the cloud, with robotic systems performing the physical tasks in Persist AI's state-of-the-art laboratory.
- Formulation Development: Utilizing AI-driven predictions and high-throughput robotic experimentation, Persist AI's scientists develop formulations that meet specific target product profiles efficiently.
- Commercial cGMP Manufacturing: Post-formulation discovery, Persist AI offers automated aseptic manufacturing lines to produce clinical and production batches, ensuring compliance with current Good Manufacturing Practice (cGMP) standards.
- Analytical Support: Comprehensive analytical capabilities, including integrated High-Performance Liquid Chromatography (HPLC), spectrophotometry, and Raman spectroscopy, provide detailed insights into each formulation.
Primary Value and User Solutions:
Persist AI addresses the critical bottleneck in drug development by significantly reducing the time and resources required for formulation discovery and optimization. By leveraging AI and robotics, the company enables pharmaceutical firms to accelerate the development of long-acting injectables and other complex formulations, improving patient compliance and outcomes. This approach not only enhances the efficiency of drug development pipelines but also facilitates the rapid introduction of innovative therapies to the market.